Shares Of Vitae Are Down 30% After Hours After Its Partner Places Alzheimer's Trial On A Voluntary Hold
February 26, 2015 at 20:20 PM EST
Vitae's partner, Boehringer Ingelheim, has decided to halt its Alzheimers trial until it resolves safety problems
